Alan Gilbert, Vice President for Policy at Purchaser Business Group on Health, discusses whether CVS’s new pharmacy reimbursement model will provide transparency and decrease drug prices; and HHS has created regulations requiring more transparency on AI used in clinical settings.

STAT News Article: CVS’s new drug payment plan won’t lower patients’ prices, experts warn

CNN News Article: CVS will change the way it prices prescription drugs

Politico News Article: HHS takes first stab at AI regs